Pertussis: Current perspectives on epidemiology and prevention

Human Vaccines and Immunotherapeutics

Volumn 11, Issue 1, 2015, Pages 108-117

  Gabutti, Giovanni ^a   Azzari, Chiara ^b   Bonanni, Paolo ^c   Prato, Rosa ^d   Tozzi, Alberto E ^e   Zanetti, Alessandro ^f   Zuccotti, Gianvincenzo ^g  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF FOGGIA   (Italy)

^e BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g UNIVERSITY OF MILAN   (Italy)

Author keywords

Epidemiology; Immunization strategies; Pertussis; Prevention; Vaccination

Indexed keywords

PERTUSSIS VACCINE;

ADOLESCENT; ADULT; AGED; CHILD; COMMUNICABLE DISEASES, EMERGING; FEMALE; HUMAN; IMMUNIZATION; IMMUNOLOGY; INFANT; MALE; MIDDLE AGED; NEWBORN; PREGNANCY; PRESCHOOL CHILD; PROCEDURES; VERY ELDERLY; WHOOPING COUGH; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES, EMERGING; FEMALE; HUMANS; IMMUNIZATION; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PERTUSSIS VACCINE; PREGNANCY; WHOOPING COUGH; YOUNG ADULT;

EID: 84920031778     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.34364     Document Type: Conference Paper

References (119)

1. Hewlett EL, Burns DL, Cotter PA, Harvill ET, Merkel TJ, Quinn CP, Stibitz ES. Pertussis pathogenesis - what we know and what we don't know. J Infect Dis 2014; 209:982-5; PMID:24626533; http://dx.doi.org/10.1093/infdis/jit639
2. Anderson RM, May RM. Infectious diseases of humans. 1st ed. Oxford, Oxford University Press; 1991
3. Kretzschmar M, Teunis PFM, Pebody RG. Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries. PLoS Med 2010; 7:e1000291; http://dx.doi.org/10.1371/journal.pmed.1000291; PMID:20585374
4. WHO. Pertussis vaccines: WHO position paper. Wkly Epidemiol Rec 2010; 85:385-400; PMID:20939150
5. Tozzi AE, Celentano LP, Ciofi degli Atti ML, Salmaso S. Diagnosis and management of pertussis. CMAJ 2005; 172:509-15; PMID:15710944; http://dx.doi.org/10.1503/cmaj.1040766
6. Donoso A, Arriagada D, Cruces P, Díaz F. Coqueluche grave: Estado del arte. Rev Chilena Infectol 2012; 29:290-306; PMID:23096468; http://dx.doi.org/10.4067/S0716-10182012000300007
7. Spector TB, Maziarz EK. Pertussis. Med Clin North Am 2013; 97:537-52, ix; PMID:23809713; http://dx.doi.org/10.1016/j.mcna.2013.02.004
8. Clark TA. Responding to pertussis. J Pediatr 2012; 161:980-2; PMID:22906510; http://dx.doi.org/10.1016/j.jpeds.2012.07.014
9. Fedele G, Bianco M, Ausiello CM. The virulence factors of Bordetella pertussis: talented modulators of host immune response. Arch Immunol Ther Exp (Warsz) 2013; 61:445-57; http://dx.doi.org/10.1007/s00005-013-0242-1; PMID:23955529
10. Clark TA. Changing pertussis epidemiology: everything old is new again. J Infect Dis 2014; 209:978-81; PMID:24626532; http://dx.doi.org/10.1093/infdis/jiu001
11. Higgs R, Higgins SC, Ross PJ, Mills KHG. Immunity to the respiratory pathogen Bordetella pertussis. Mucosal Immunol 2012; 5:485-500; PMID:22718262; http://dx.doi.org/10.1038/mi.2012.54
12. Ross PJ, Sutton CE, Higgins S, Allen AC, Walsh K, Misiak A, Lavelle EC, McLoughlin RM, Mills KH. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog 2013; 9:e1003264; http://dx.doi.org/10.1371/journal.ppat.1003264; PMID:23592988
13. Mooi FR, van Loo IH, van Gent M, He Q, Bart MJ, Heuvelman KJ, de Greeff SC, Diavatopoulos D, Teunis P, Nagelkerke N, et al. Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis 2009; 15:1206-13; PMID:19751581; http://dx.doi.org/10.3201/eid1508.081511
14. Queenan AM, Cassiday PK, Evangelista A. Pertactin-negative variants of Bordetella pertussis in the United States. N Engl J Med 2013; 368:583-4; PMID:23388024; http://dx.doi.org/10.1056/NEJMc1209369
15. de Gouw D, Hermans PWM, Bootsma HJ, Zomer A, Heuvelman K, Diavatopoulos DA, Mooi FR. Differentially expressed genes in Bordetella pertussis strains belonging to a lineage which recently spread globally. PLoS One 2014; 9:e84523; http://dx.doi.org/10.1371/journal.pone.0084523; PMID:24416242
16. Lam C, Octavia S, Ricafort L, Sintchenko V, Gilbert GL, Wood N, McIntyre P, Marshall H, Guiso N, Keil AD, et al. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia. Emerg Infect Dis 2014; 20:626-33; PMID:24655754; http://dx.doi.org/10.3201/eid2004.131478
17. WHO. Immunization, surveillance assessment and monitoring. Pertussis. 2012 global figures; www.who.int/immunization-monitoring/diseases/pertussis last update 23 July 2013 (Last access April 2014)
18. Clark TA, Messonnier NE, Hadler SC. Pertussis control: time for something new? Trends Microbiol 2012; 20:211-3; PMID:22494804; http://dx.doi.org/10.1016/j.tim.2012.03.003
19. Centers for Disease Control and Prevention (CDC). 2012 final pertussis surveillance report; www.cdc.gov/pertussis/downloads/pertuss-surv-report-2012.pdf October 18, 2013 (last access April 2014)
20. Centers for Disease Control and Prevention (CDC). Pertussis (whooping cough). Surveillance & reports. Trends; www.cdc.gov/pertussis/surv-reporting.html March 19, 2014 (last access April 2014)
21. Centers for Disease Control and Prevention (CDC). Pertussis epidemic - Washington, 2012. MMWR Morb Mortal Wkly Rep 2012; 61:517-22; PMID:22810264
22. Centers for Disease Control and Prevention (CDC).. Pertussis outbreak in an Amish community - Kent County, Delaware, September 2004-February 2005 MMWR. 2006;55(30):817-21
23. Centers for Disease Control and Prevention (CDC). Use of mass Tdap vaccination to control an outbreak of pertussis in a high school - Cook County, Illinois, September 2006-January 2007. MMWR Morb Mortal Wkly Rep 2008; 57:796-9; PMID:18650787
24. Misegades LK, Winter K, Harriman K, Talarico J, Messonnier NE, Clark TA, Martin SW. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. JAMA 2012; 308:2126-32; PMID:23188029; http://dx.doi.org/10.1001/jama.2012.14939
25. EUVAC.NET. Pertussis surveillance report 2003-2007. www.euvac.net 2009, (last access April 2014)
26. EUVAC.NET. Pertussis surveillance report 2010; ecdc.europa.eu/en/publications/Publications/pertussis-report-2010-euvacnet.pdf, issued 5 August 2011 (Last access April 2014)
27. Giammanco A, Chiarini A, Maple PAC, Andrews N, Pebody R, Gay N, Olander RM, Fivet-Groyne F, Baron S, Tischer A, et al. European Sero-Epidemiology Network: standardisation of the assay results for pertussis. Vaccine 2003; 22:112-20; PMID:14604578; http://dx.doi.org/10.1016/S0264-410X(03)00514-0
28. Pebody RG, Gay NJ, Giammanco A, Baron S, Schellekens J, Tischer A, Olander RM, Andrews NJ, Edmunds WJ, Lecoeur H, et al. The sero-epidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect 2005; 133:159-71; PMID:15724723; http://dx.doi.org/10.1017/S0950268804003012
29. Rota MC, D'Ancona F, Massari M, Mandolini D, Giammanco A, Carbonari P, Salmaso S, Ciofi degli Atti ML. How increased pertussis vaccination coverage is changing the epidemiology of pertussis in Italy. Vaccine 2005; 23:5299-305; PMID:16112254; http://dx.doi.org/10.1016/j.vaccine.2005.07.061
30. ISS. Gruppo di Lavoro ICONA. Indagine 2008: indagine di copertura vaccinale nazionale nei bambini e negli adolescenti. Rapporti ISTISAN 2009, 09/29
31. Gabutti G, Bergamini M, Bonanni P, Guido M, Fenoglio D, Giammanco A, Sindoni L, Zotti C, Boddi V, Bamfi F, et al.; Collaborative Group for the Study of Pertussis. Assessment of humoral and cell-mediated immunity against Bordetella pertussis in adolescent, adult, and senior subjects in Italy. Epidemiol Infect 2008; 136:1576-84; PMID:18198000
32. Gabutti G, Rota MC, Bonato B, Pirani R, Turlà G, Cucchi A, Cavallaro A. Hospitalizations for pertussis in Italy, 1999-2009: analysis of the hospital discharge database. [Erratum appears in Eur J Pediatr. 2013; 172: 1425]. Eur J Pediatr 2012; 171:1651-5; PMID:22790868; http://dx.doi.org/10.1007/s00431-012-1791-8
33. Poland GA. Pertussis outbreaks and pertussis vaccines: new insights, new concerns, new recommendations? Vaccine 2012; 30:6957-9; PMID:23141958; http://dx.doi.org/10.1016/j.vaccine.2012.09.084
34. Ridda I, Yin JK, King C, Raina MacIntyre C, McIntyre P. The importance of pertussis in older adults: a growing case for reviewing vaccination strategy in the elderly. Vaccine 2012; 30:6745-52; PMID:22981762
35. Chiappini E, Stival A, Galli L, de Martino M. Pertussis re-emergence in the post-vaccination era. BMC Infect Dis 2013; 13:151; PMID:23530907; http://dx.doi.org/10.1186/1471-2334-13-151
36. van der Maas NAT, Mooi FR, de Greeff SC, Berbers GAM, Spaendonck MA, de Melker HE. Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants? Vaccine 2013; 31:4541-7; PMID:23933365; http://dx.doi.org/10.1016/j.vaccine.2013.07.060
37. Frumkin K. Pertussis and persistent cough: practical, clinical and epidemiologic issues. J Emerg Med 2013; 44:889-95; PMID:23287746; http://dx.doi.org/10.1016/j.jemermed.2012.09.037
38. Guiso N, Wirsing von König CH, Forsyth K, Tan T, Plotkin SA. The Global Pertussis Initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11-12 January 2010. Vaccine 2011; 29:1115-21; PMID:21168525; http://dx.doi.org/10.1016/j.vaccine.2010.12.010
39. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2095-128; PMID:23245604; http://dx.doi.org/10.1016/S0140-6736(12)61728-0
40. Marzouqi I, Richmond P, Fry S, Wetherall J, Mukkur T. Development of improved vaccines against whooping cough: current status. Hum Vaccin 2010; 6:543-53; PMID:20448470; http://dx.doi.org/10.4161/hv.6.7.11413
41. Cherry JD. Historical review of pertussis and the classical vaccine. J Infect Dis 1996; 174(Suppl 3):S259-63; PMID:8896526; http://dx.doi.org/10.1093/infdis/174.Supplement-3.S259
42. Dias WO, van der Ark AAJ, Sakauchi MA, Kubrusly FS, Prestes AFRO, Borges MM, Furuyama N, Horton DS, Quintilio W, Antoniazi M, et al. An improved whole cell pertussis vaccine with reduced content of endotoxin. Hum Vaccin Immunother 2013; 9:339-48; PMID:23291935; http://dx.doi.org/10.4161/hv.22847
43. Guiso N. How to fight pertussis? Ther Adv Vaccines 2013; 1:59-66; PMID:24757515; http://dx.doi.org/10.1177/2051013613481348
44. WHO. Improvements in the control of whooping cough. WER 1995; 35:255-6
45. Bar-On ES, Goldberg E, Hellmann S, Leibovici L. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB). Cochrane Database Syst Rev 2012; 4:CD005530; PMID:22513932; http://dx.doi.org/10.1002/14651858:CD005530.pub3
46. Ray P, Hayward J, Michelson D, Lewis E, Schwalbe J, Black S, Shinefield H, Marcy M, Huff K, Ward J, et al.; Vaccine Safety Datalink Group. Encephalopathy after whole-cell pertussis or measles vaccination: lack of evidence for a causal association in a retrospective case-control study. Pediatr Infect Dis J 2006; 25:768-73; PMID:16940831; http://dx.doi.org/10.1097/01.inf.0000234067.84848.e1
47. Cherry JD. Pertussis: the trials and tribulations of old and new pertussis vaccines. Vaccine 1992; 10:1033-8; PMID:1471425; http://dx.doi.org/10.1016/0264-410X(92)90113-X
48. Storsaeter J, Hallander HO, Gustafsson L, Olin P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 1998; 16:1907-16; PMID:9796042; http://dx.doi.org/10.1016/S0264-410X(98)00227-8
49. Olin P, Hallander HO, Gustafsson L, Reizenstein E, Storsaeter J. How to make sense of pertussis immunogenicity data. Clin Infect Dis 2001; 33(Suppl 4):S288-91; PMID:11709761; http://dx.doi.org/10.1086/322564
50. Mills KHG. Immunity to Bordetella pertussis. Microbes Infect 2001; 3:655-77; PMID:11445452; http://dx.doi.org/10.1016/S1286-4579(01)01421-6
51. Storsaeter J, Olin P. Relative efficacy of two acellular pertussis vaccines during three years of passive surveillance. Vaccine 1992; 10:142-4; PMID:1557928; http://dx.doi.org/10.1016/0264-410X(92)90002-2
52. Rota MC, Ausiello CM, D'Amelio R, Cassone A, Giammanco A, Molica C, Lande R, Greco D, Salmaso S. Prevalence of markers of exposure to Bordetella pertussis among Italian young adults. Clin Infect Dis 1998; 26:297-302; PMID:9502445; http://dx.doi.org/10.1086/516293
53. Tran Minh NN, He Q, Edelman K, Olander RM, Viljanen MK, Arvilommi H, Mertsola J. Cell-mediated immune responses to antigens of Bordetella pertussis and protection against pertussis in school children. Pediatr Infect Dis J 1999; 18:366-70; PMID:10223692; http://dx.doi. org/10.1097/00006454-199904000-00012
54. Rieber N, Graf A, Hartl D, Urschel S, Belohradsky BH, Liese J. Acellular pertussis booster in adolescents induces Th1 and memory CD8+ T cell immune response. PLoS One 2011; 6:e17271; PMID:21408149; http://dx.doi.org/10.1371/journal.pone.0017271
55. Bernstein HH, Rothstein EP, Pichichero ME, Green JL, Reisinger KS, Blatter MM, Halpern J, Arbeter AM, Bernstein DI, Smith V, et al. Reactogenicity and immunogenicity of a three-component acellular pertussis vaccine administered as the primary series to 2, 4 and 6 month old infants in the United States. Vaccine 1995; 13:1631-5; PMID:8719512; http://dx.doi.org/10.1016/0264-410X(95)00137-P
56. Chang S, O'Connor PM, Slade BA, Woo EJUS. U.S. Postlicensure safety surveillance for adolescent and adult tetanus, diphtheria and acellular pertussis vaccines: 2005-2007. Vaccine 2013; 31:1447-52; PMID:23142308; http://dx.doi.org/10.1016/j.vaccine.2012.10.097
57. Taranger J, Trollfors B, Bergfors E, Knutsson N, Sundh V, Lagergård T, Lind-Brandberg L, Zackrisson G, White J, Cicirello H, et al. Mass vaccination of children with pertussis toxoid - decreased incidence in both vaccinated and nonvaccinated persons. Clin Infect Dis 2001; 33:1004-10; PMID:11528572; http://dx.doi.org/10.1086/322639
58. Hallander HO, Gustafsson L. Efficacy and effectiveness of acellular pertussis vaccines: a 20-year Swedish experience. Expert Rev Vaccines 2009; 8:1303-7; PMID:19803750; http://dx.doi.org/10.1586/erv.09.88
59. Trollfors B, Dotevall L, Sundh V, Welinder-Olsson C. Pertussis after end of a mass vaccination project - end of the "vaccination honey-moon". Vaccine 2011; 29:2444-50; PMID:21292010; http://dx.doi.org/10.1016/j.vaccine.2011.01.021
60. Hviid A, Stellfeld M, Andersen PH, Wohlfahrt J, Melbye M. Impact of routine vaccination with a pertussis toxoid vaccine in Denmark. Vaccine 2004; 22:3530-4; PMID:15315832; http://dx.doi.org/10.1016/j.vaccine.2004.03.046
61. Thierry-Carstensen B, Dalby T, Stevner MA, Robbins JB, Schneerson R, Trollfors B. Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults - a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience. Vaccine 2013; 31:5178-91; PMID:23994021; http://dx.doi.org/10.1016/j.vaccine.2013.08.034
62. Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, Glodé MP, Ehresmann KR, and the Pertussis Investigation Team. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Pediatrics 2005; 116:e285-94; PMID:16061582; http://dx.doi.org/10.1542/peds.2004-2759
63. Tartof SY, Lewis M, Kenyon C, White K, Osborn A, Liko J, Zell E, Martin S, Messonnier NE, Clark TA, et al. Waning immunity to pertussis following 5 doses of DTaP. Pediatrics 2013; 131:e1047-52; PMID:23478868; http://dx.doi.org/10.1542/peds.2012-1928
64. Rendi-Wagner P, Kundi M, Mikolasek A, Vécsei A, Frühwirth M, Kollaritsch H. Hospital-based active surveillance of childhood pertussis in Austria from 1996 to 2003: estimates of incidence and vaccine effectiveness of whole-cell and acellular vaccine. Vaccine 2006; 24:5960-5; PMID:16757063; http://dx.doi.org/10.1016/j.vaccine.2006.05.011
65. van der Maas NAT, Mooi FR, de Greeff SC, Berbers GAM, Spaendonck MA, de Melker HE. Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants? Vaccine 2013; 31:4541-7; PMID:23933365; http://dx.doi.org/10.1016/j.vaccine.2013.07.060
66. Baxter R, Bartlett J, Rowhani-Rahbar A, Fireman B, Klein NP. Effectiveness of pertussis vaccines for adolescents and adults: case-control study. BMJ 2013; 347:f4249; http://dx.doi.org/10.1136/bmj.f4249; PMID:23873919
67. Klein NP, Bartlett J, Fireman B, Rowhani-Rahbar A, Baxter R. Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers. Pediatrics 2013; 131:e1716-22; PMID:23690518; http://dx.doi.org/10.1542/peds.2012-3836
68. Gabutti G, Trucchi C, Conversano M, Zivelonghi G, Zoppi G. Booster vaccination: the role of reduced antigen content vaccines as a preschool booster. Biomed Res Int 2014; 2014:541319; PMID:24678509; http://dx.doi.org/10.1155/2014/541319
69. Bechini A, Tiscione E, Boccalini S, Levi M, Bonanni P. Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations. Vaccine 2012; 30:5179-90; PMID:22709953; http://dx.doi.org/10.1016/j.vaccine.2012.06.005
70. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005; 24(Suppl):S58-61; PMID:15876927; http://dx.doi.org/10.1097/01.inf.0000160914.59160.41
71. Lavine JS, King AA, Bjørnstad ON. Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure. Proc Natl Acad Sci U S A 2011; 108:7259-64; PMID:21422281; http://dx.doi.org/10.1073/pnas.1014394108
72. Arinaminpathy N, Lavine JS, Grenfell BT. Selfboosting vaccines and their implications for herd immunity. Proc Natl Acad Sci U S A 2012; 109:20154-9; PMID:23169630; http://dx.doi.org/10.1073/pnas.1209683109
73. Campins M, Moreno-Pérez D, Gil-de Miguel A, González-Romo F, Moraga-Llop FA, Arístegui-Fernández J, Goncé-Mellgren A, Bayas JM, Salleras-Sanmartí L. Tos ferina en España. Situación epidemiológica y estrategias de prevención y control. Recomendaciones del Grupo de Trabajo de Tos ferina. Enferm Infecc Microbiol Clin 2013; 31:240-53; PMID:23411362; http://dx.doi.org/10.1016/j.eimc.2012.12.011
74. Wiley KE, Zuo Y, Macartney KK, McIntyre PB. Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy. Vaccine 2013; 31:618-25; PMID:23200883; http://dx.doi.org/10.1016/j.vaccine.2012.11.052
75. McGuiness CB, Hill J, Fonseca E, Hess G, Hitchcock W, Krishnarajah G. The disease burden of pertussis in adults 50 years old and older in the United States: a retrospective study. BMC Infect Dis 2013; 13:32; PMID:23343438; http://dx.doi.org/10.1186/1471-2334-13-32
76. Rønn PF, Dalby T, Simonsen J, Jørgensen CS, Linneberg A, Krogfelt KA. Seroepidemiology of pertussis in a cross-sectional study of an adult general population in Denmark. Epidemiol Infect 2014; 142:729-37; PMID:24103353; http://dx.doi.org/10.1017/S0950268813002446
77. Gonfiantini MV, Villani A, Gesualdo F, Pandolfi E, Agricola E, Bozzola E, Arigliani R, Tozzi AE. Attitude of Italian physicians toward pertussis diagnosis. Hum Vaccin Immunother 2013; 9:1485-8; PMID:23732898; http://dx.doi.org/10.4161/hv.24734
78. Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 2008; 5:e74; PMID:18366252; http://dx.doi.org/10.1371/journal.pmed.0050074
79. WHO Publication. Pertussis vaccines: WHO position paper - recommendations. Vaccine 2011; 29:2355-6; PMID:21129396; http://dx.doi.org/10.1016/j.vaccine.2010.11.059
80. ECDC. ECDC guidance: Scientific panel on childhood immunization schedule: Diphtheriatetanus-pertussis (DTP) vaccination. Stockholm, 2009; http://www.ecdc.europa.eu/en/publications/Publications/0911-GUI-ScientificPanel-on-Childhood-Immunisation-DTP.pdf
81. Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE; EUVAC-NET Group. Resurgence of pertussis in Europe. Pediatr Infect Dis J 2005; 24:761-5; PMID:16148840; http://dx.doi.org/10.1097/01.inf.0000177282.53500.77
82. Campbell H, Amirthalingam G, Andrews N, Fry NK, George RC, Harrison TG, Miller E. Accelerating control of pertussis in England and Wales. Emerg Infect Dis 2012; 18:38-47; PMID:22260989; http://dx.doi.org/10.3201/eid1801.110784
83. Amirthalingam G. Strategies to control pertussis in infants. Arch Dis Child 2013; 98:552-5; PMID:23698594; http://dx.doi.org/10.1136/archdischild-2012-302968
84. Shinall MC Jr., Peters TR, Zhu Y, Chen Q, Poehling KA. Potential impact of acceleration of the pertussis vaccine primary series for infants. Pediatrics 2008; 122:1021-6; PMID:18977982; http://dx.doi.org/10.1542/peds.2007-3025
85. Foxwell AR, McIntyre P, Quinn H, Roper K, Clements MS. Severe pertussis in infants: estimated impact of first vaccine dose at 6 versus 8 weeks in australia. Pediatr Infect Dis J 2011; 30:161-3; PMID:20811313; http://dx.doi.org/10.1097/INF.0b013e3181f43906
86. de Greeff SC, Mooi FR, Schellekens JF, de Melker HE. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands. Pediatr Infect Dis J 2008; 27:218-23; PMID:18277916; http://dx.doi.org/10.1097/INF.0b013e318161a2b9
87. Gustafsson L, Hessel L, Storsaeter J, Olin P. Longterm follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age. Pediatrics 2006; 118:978-84; PMID:16950988; http://dx.doi.org/10.1542/peds.2005-2746
88. EUVAC-NET. Pertussis surveillance. Final report; http://ecdc.europa.eu/en/publications/Publications/pertussis-report-1998-2002.pdf (Last access April 2014)
89. Hellenbrand W, Beier D, Jensen E, Littmann M, Meyer C, Oppermann H, Wirsing von König CH, Reiter S. The epidemiology of pertussis in Germany: past and present. BMC Infect Dis 2009; 9:22; PMID:19243604; http://dx.doi.org/10.1186/1471-2334-9-22
90. Zepp F, Heininger U, Mertsola J, Bernatowska E, Guiso N, Roord J, Tozzi AE, Van Damme P. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis 2011; 11:557-70; PMID:21600850; http://dx.doi.org/10.1016/S1473-3099(11)70007-X
91. Bisgard KM, Pascual FB, Ehresmann KR, Miller CA, Cianfrini C, Jennings CE, Rebmann CA, Gabel J, Schauer SL, Lett SM. Infant pertussis: who was the source? Pediatr Infect Dis J 2004; 23:985-9; PMID:15545851; http://dx.doi.org/10.1097/01.inf.0000145263.37198.2b
92. Centers for Disease Control and Prevention (CDC). Use of mass Tdap vaccination to control an outbreak of pertussis in a high school - Cook County, Illinois, September 2006-January 2007. MMWR Morb Mortal Wkly Rep 2008; 57:796-9; PMID:18650787
93. Wong CA, Taylor JA, Wright JA, Opel DJ, Katzenellenbogen RA. Missed opportunities for adolescent vaccination, 2006-2011. J Adolesc Health 2013; 53:492-7; PMID:23809613; http://dx.doi.org/10.1016/j.jadohealth.2013.05.009
94. ECDC. Vaccine schedule; http://vaccine-schedule.ecdc.europa.eu/Pages/Scheduler.aspx (Last access April 2014)
95. Wendelboe AM, Njamkepo E, Bourillon A, Floret DD, Gaudelus J, Gerber M, Grimprel E, Greenberg D, Halperin S, Liese J, et al.; Infant Pertussis Study Group. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 2007; 26:293-9; PMID:17414390; http://dx.doi.org/10.1097/01.inf.0000258699.64164.6d
96. McGuiness CB, Hill J, Fonseca E, Hess G, Hitchcock W, Krishnarajah G. The disease burden of pertussis in adults 50 years old and older in the United States: a retrospective study. BMC Infect Dis 2013; 13:32; PMID:23343438; http://dx.doi.org/10.1186/1471-2334-13-32
97. Centers for Disease Control and Prevention (CDC). Recommended adult immunization schedule United States 2013; http://www.cdc.gov/vaccines/schedules/downloads/adult/adult-schedule.pdf
98. de Greeff SC, Mooi FR, Westerhof A, Verbakel JM, Peeters MF, Heuvelman CJ, Notermans DW, Elvers LH, Schellekens JF, de Melker HE. Pertussis disease burden in the household: how to protect young infants. Clin Infect Dis 2010; 50:1339-45; PMID:20370464; http://dx.doi.org/10.1086/652281
99. Halperin BA, Morris A, Mackinnon-Cameron D, Mutch J, Langley JM, McNeil SA, Macdougall D, Halperin SA. Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women. Clin Infect Dis 2011; 53:885-92; PMID:21946190; http://dx.doi.org/10.1093/cid/cir538
100. Castagnini LA, Healy CM, Rench MA, Wootton SH, Munoz FM, Baker CJ. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clin Infect Dis 2012; 54:78-84; PMID:22075790; http://dx.doi.org/10.1093/cid/cir765
101. Frère J, De Wals P, Ovetchkine P, Coïc L, Audibert F, Tapiero B. Evaluation of several approaches to immunize parents of neonates against B. pertussis. Vaccine 2013; 31:6087-91; PMID:24099874; http://dx.doi.org/10.1016/j.vaccine.2013.09.043
102. Skowronski DM, Janjua NZ, Tsafack EP, Ouakki M, Hoang L, De Serres G. The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunization. Clin Infect Dis 2012; 54:318-27; PMID:22156850; http://dx.doi.org/10.1093/cid/cir836
103. Tozzi AE, Vitali Rosati G, Ciarrocchi G, Ferrera G, Gabutti G, Giuffrida S, et al. Riduzione del rischio di pertosse nel neonato mediante vaccinazione: la strategia cocoon in Italia. RIAP 2012; 2(S2):1-10
104. Conyn MAE, van der Maas NAT, Mooi FM. RIVM Letter report 215121002/2012. Control of whooping cough in the Netherlands. Optimisation of the vaccination policy. RIVM, 2012
105. Belloni C, De Silvestri A, Tinelli C, Avanzini MA, Marconi M, Strano F, Rondini G, Chirico G. Immunogenicity of a three-component acellular pertussis vaccine administered at birth. Pediatrics 2003; 111:1042-5; PMID:12728086; http://dx.doi.org/10.1542/peds.111.5.1042
106. Halasa NB, O'Shea A, Shi JR, LaFleur BJ, Edwards KM. Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine. J Pediatr 2008; 153:327-32; PMID:18534242; http://dx.doi.org/10.1016/j.jpeds.2008.03.011
107. Knuf M, Schmitt HJ, Wolter J, Schuerman L, Jacquet JM, Kieninger D, Siegrist CA, Zepp F. Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. J Pediatr 2008; 152:655-60, e1; PMID:18410769; http://dx.doi.org/10.1016/j.jpeds.2007.09.034
108. Wood N, McIntyre P, Marshall H, Roberton D. Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age. Pediatr Infect Dis J 2010; 29:209-15; PMID:20009964; http://dx.doi.org/10.1097/INF.0b013e3181bc98d5
109. White OJ, Rowe J, Richmond P, Marshall H, McIntyre P, Wood N, Holt PG. Th2-polarisation of cellular immune memory to neonatal pertussis vaccination. Vaccine 2010; 28:2648-52; PMID:20096390; http://dx.doi.org/10.1016/j.vaccine.2010.01.010
110. Leuridan E, Hens N, Peeters N, de Witte L, Van der Meeren O, Van Damme P. Effect of a prepregnancy pertussis booster dose on maternal antibody titers in young infants. Pediatr Infect Dis J 2011; 30:608-10; PMID:21206396; http://dx.doi.org/10.1097/INF.0b013e3182093814
111. Healy CM, Rench MA, Baker CJ. Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants. Clin Infect Dis 2013; 56:539-44; PMID:23097585; http://dx.doi.org/10.1093/cid/cis923
112. Siegrist CA. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine 2003; 21:3406-12; PMID:12850349; http://dx.doi.org/10.1016/S0264-410X(03)00342-6
113. Zheteyeva YA, Moro PL, Tepper NK, Rasmussen SA, Barash FE, Revzina NV, Kissin D, Lewis PW, Yue X, Haber P, et al. Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol 2012; 207:e1-7, e7; PMID:22727350; http://dx.doi.org/10.1016/j.ajog.2012.05.006
114. Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women - Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 2013; 62:131-5; PMID:23425962
115. Gall SA, Myers J, Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol 2011; 204:e1-5, e5; PMID:21272845; http://dx.doi.org/10.1016/j.ajog.2010.11.024
116. Kaltsas A, Sepkowitz K. Vaccinations for healthcare personnel: update on influenza, hepatitis B, and pertussis. Curr Opin Infect Dis 2013; 26:366-77; PMID:23806899
117. Sandora TJ, Gidengil CA, Lee GM. Pertussis vaccination for health care workers. Clin Microbiol Rev 2008; 21:426-34; PMID:18625679; http://dx.doi.org/10.1128/CMR.00003-08
118. Elumogo TN, Booth D, Enoch DA, Kuppuswamy A, Tremlett C, Williams CJ, Shankar A, Morter S. Bordetella pertussis in a neonatal intensive care unit: identification of the mother as the likely source. J Hosp Infect 2012; 82:133-5; PMID:22940441; http://dx.doi.org/10.1016/j.jhin.2012.07.012
119. Cohen S, Black A, Ross A, Mandel ED. Updated treatment and prevention guidelines for pertussis. JAAPA 2014; 27:19-25, quiz 26; PMID:24321856; http://dx.doi.org/10.1097/01.JAA.0000438528.61644.91